MedPath

An Observational and Analytical Study to Evaluate Heart Diseases with ECG,2D Echo and Fasting Lipid Profile

Not Applicable
Conditions
Health Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I019- Acute rheumatic heart disease, unspecifiedHealth Condition 3: I209- Angina pectoris, unspecifiedHealth Condition 4: I110- Hypertensive heart disease with heart failureHealth Condition 5: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereHealth Condition 6: I089- Rheumatic multiple valve disease,unspecified
Registration Number
CTRI/2023/08/056260
Lead Sponsor
Parul Institute of Ayurved
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Diagnosed cases of Heart Diseases like Angina and Myocardial Infarction, Heart Failure, Rheumatic Heart Disease, Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, Carditis, Aortic aneurysms etc. patients with symptoms of Hridroga.

2 Patients diagnosed with post covid cardiac disorder.

3 Duration of disease â?? 0-10 yrs,10 - 20 yrs ,20 - 30 yrs,30-40 yrs. (with 10 years duration)

Exclusion Criteria

1 Patients diagnosed with symptoms of Krimaj Hridroga.

2 Patient having major ailments of other systems. Eg CA of any organs, Hepatitis B and C, Pregnancy, TB etc. at the time of enrolling the patients.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
As this is an Observational study & i am going to assess the relation between types of hridroga based on ECG, Echo & Fasting lipid profile with duration of disease.There may be some changes which i will get or there may be nothing significant finding. Here we are going to establish the relation in hridroga types on the basis of symptoms and investigationsTimepoint: 18 MONTH
Secondary Outcome Measures
NameTimeMethod
As this is observational study I am going to observe the relation between the duration of onset of the study & its impact on the ECG & 2D echo & fasting lipid profileTimepoint: 12 MONTHS
© Copyright 2025. All Rights Reserved by MedPath